Our Technology

ArteraAI Prostate Test

  • Our AI tool learns from patient-level clinical data and unannotated pathology slides to prognosticate long-term outcomes.
  • Using five NRG Oncology Phase III randomized clinical trials,we’ve trained and validated prognostic biomarkers in localized prostate cancer.
  • To learn more about using the Artera AI Prostate Prognostic tool, please contact: info@artera.ai